| Elie R Soussan, MD | |
|
34 Sycamore Ave, Suite 2a, Little Silver, NJ 07739-1228 | |
| (732) 747-9310 | |
| (732) 747-9320 |
| Full Name | Elie R Soussan |
|---|---|
| Gender | Male |
| Speciality | Obstetrics & Gynecology |
| Location | 34 Sycamore Ave, Little Silver, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891958674 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 25MA08834200 (New Jersey) | Primary |
| Entity Name | Lifeline Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821041617 PECOS PAC ID: 1456332170 Enrollment ID: O20040528000067 |
News Archive
Adolescents who are bullied about their weight or body shape may be more likely to use alcohol or marijuana than those who are not bullied, according to new research published by the American Psychological Association.
For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand and sheer force through a patient's skin and bone, and the procedure is often described as "brutal," "excruciating" and even "barbaric."
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
Advaxis, Inc.,, a leader in developing the next generation of cancer immunotherapies, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated head and neck cancer.
› Verified 5 days ago
| Entity Name | Barnabas Health Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841557246 PECOS PAC ID: 9537316955 Enrollment ID: O20120820000951 |
News Archive
Adolescents who are bullied about their weight or body shape may be more likely to use alcohol or marijuana than those who are not bullied, according to new research published by the American Psychological Association.
For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand and sheer force through a patient's skin and bone, and the procedure is often described as "brutal," "excruciating" and even "barbaric."
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
Advaxis, Inc.,, a leader in developing the next generation of cancer immunotherapies, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated head and neck cancer.
› Verified 5 days ago
| Entity Name | Womens Comprehensive Health Care Of New Jersey |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912246257 PECOS PAC ID: 6103067897 Enrollment ID: O20130723000256 |
News Archive
Adolescents who are bullied about their weight or body shape may be more likely to use alcohol or marijuana than those who are not bullied, according to new research published by the American Psychological Association.
For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand and sheer force through a patient's skin and bone, and the procedure is often described as "brutal," "excruciating" and even "barbaric."
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
Advaxis, Inc.,, a leader in developing the next generation of cancer immunotherapies, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated head and neck cancer.
› Verified 5 days ago
| Entity Name | Mmc Provider Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932647872 PECOS PAC ID: 9133555626 Enrollment ID: O20200131000598 |
News Archive
Adolescents who are bullied about their weight or body shape may be more likely to use alcohol or marijuana than those who are not bullied, according to new research published by the American Psychological Association.
For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand and sheer force through a patient's skin and bone, and the procedure is often described as "brutal," "excruciating" and even "barbaric."
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
Advaxis, Inc.,, a leader in developing the next generation of cancer immunotherapies, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated head and neck cancer.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elie R Soussan, MD 34 Sycamore Ave, Suite 2a, Little Silver, NJ 07739-1228 Ph: (732) 747-9310 | Elie R Soussan, MD 34 Sycamore Ave, Suite 2a, Little Silver, NJ 07739-1228 Ph: (732) 747-9310 |
News Archive
Adolescents who are bullied about their weight or body shape may be more likely to use alcohol or marijuana than those who are not bullied, according to new research published by the American Psychological Association.
For many cancer patients, a bone marrow biopsy and/or aspiration is one of the most dreaded aspects of their diagnosis and treatment plan. The traditional method for gaining bone marrow involves grinding a needle by hand and sheer force through a patient's skin and bone, and the procedure is often described as "brutal," "excruciating" and even "barbaric."
Serametrix Corporation, a personalized medicine company, today announced their partnership with the Ludwig Institute for Cancer Research Ltd. (LICR). The agreement will combine LICR's historic discoveries in tumor immunology with the technologies and commercial capabilities of Serametrix. This new alliance will enable rapid development and commercialization of tests that predict and monitor drug response in cancer patients. The serum-based tests, which determine immune reaction to tumor antigens, are of value to clinicians and drug developers alike.
Advaxis, Inc.,, a leader in developing the next generation of cancer immunotherapies, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration Office of Orphan Products Development for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus-associated head and neck cancer.
› Verified 5 days ago
Dr. Katherine Ann Bohnert, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 34 Sycamore Ave Ste 2a, Little Silver, NJ 07739 Phone: 732-747-9310 Fax: 732-747-9320 | |
Dr. Shirley W Tsong, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 180 White Rd, Suite 209, Little Silver, NJ 07739 Phone: 732-842-0673 Fax: 732-842-7352 | |
Dr. Mindy E Wiser-estin, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 200 White Rd, Ste 105, Little Silver, NJ 07739 Phone: 732-741-3331 Fax: 732-741-5119 | |
Dr. Lauren Mason-cederberg, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 White Rd Ste 105, Little Silver, NJ 07739 Phone: 732-741-3331 | |
Dr. Andrew Nicholas Sun, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 White Rd, Suite 105, Little Silver, NJ 07739 Phone: 732-741-3331 Fax: 732-741-5119 | |
Dr. Eugene H Kaskiw, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 180 White Rd, Suite 209, Little Silver, NJ 07739 Phone: 732-842-0673 Fax: 732-842-7352 | |
Dr. William Nathan Kaufman, DO Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 200 White Rd, Suite 105, Little Silver, NJ 07739 Phone: 732-741-3331 Fax: 732-741-5119 |